Skip to main content
SpringerLink
Log in

Molecular Vaccines

From Prophylaxis to Therapy - Volume 2

  • Book
  • © 2014

Overview

Editors:
  1. Matthias Giese

    1. Institute for Molecular Vaccines, Heidelberg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Reviews aspects of NINC vaccine development

  • Illustrates the complete process of vaccine development from bench to preclinical and clinical studies and launch to the market

  • Enriches understanding of the use of nanotechnology in vaccine development

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (30 chapters)

  1. Front Matter

    Pages i-xxviii
    Download chapter PDF

  2. Noninfectious and Noncancer (NINC) Vaccines

    1. Front Matter

      Pages 449-450
      Download chapter PDF

    2. Vaccines for Hypertension and Atherosclerosis

      • Hiroyuki Sasamura, Tasuhiko Azegami, Hiroshi Itoh
      Pages 451-461

    3. Anti-ghrelin Therapeutic Vaccine: A Novel Approach for Obesity Treatment

      • Sara Andrade, Marcos Carreira, Felipe F. Casanueva, Polly Roy, Mariana P. Monteiro
      Pages 463-476

    4. Vaccines for Type 1 Diabetes

      • Sandeep Kumar Gupta
      Pages 477-488

    5. Novel Vaccines for Type I Allergy

      • Sandra Scheiblhofer, Josef Thalhamer, Richard Weiss
      Pages 489-501

    6. Rice Seed-Based Allergy Vaccines: Induction of Allergen-Specific Oral Tolerance Against Cedar Pollen and House Dust Mite Allergies

      • Fumio Takaiwa, Takachika Hiroi
      Pages 503-516

  3. Adjuvants and Nanotechnology

    1. Front Matter

      Pages 517-518
      Download chapter PDF

    2. Laser for Skin Vaccine Delivery and Adjuvantation

      • Xinyuan Chen, Mei X. Wu
      Pages 519-525

    3. Bacterial Lipopolysaccharide as Adjuvants

      • Jesús Arenas
      Pages 527-536

    4. Bacterial Toxins Are Successful Immunotherapeutic Adjuvants and Immunotoxins

      • Irena Adkins
      Pages 537-549

    5. Plant Heat-Shock Protein-Based Self-Adjuvanted Immunogens

      • Selene Baschieri
      Pages 551-560

    6. Functionalised Nanoliposomes for Construction of Recombinant Vaccines: Lyme Disease as an Example

      • Jaroslav Turánek, Josef MaÅ¡ek, Michal KÅ™upka, Milan RaÅ¡ka
      Pages 561-577

    7. Emerging Nanotechnology Approaches for Pulmonary Delivery of Vaccines

      • Amit K. Goyal, Goutam Rath, Basant Malik
      Pages 579-601

    8. Antigen Delivery Systems as Oral Adjuvants

      • Carlos Gamazo, Juan M. Irache
      Pages 603-622

    9. Chitosan-Based Adjuvants

      • Guro Gafvelin, Hans Grönlund
      Pages 623-631

    10. Mechanism of Adjuvanticity of Aluminum-Containing Formulas

      • Mirjam Kool, Bart N. Lambrecht
      Pages 633-642

    11. From Polymers to Nanomedicines: New Materials for Future Vaccines

      • Philipp Heller, David Huesmann, Martin Scherer, Matthias Barz
      Pages 643-671

  4. In Silico and Delivery Systems

    1. Front Matter

      Pages 673-675
      Download chapter PDF

    2. Considerations for Vaccine Design in the Postgenomic Era

      • Christine Maritz-Olivier, Sabine Richards
      Pages 677-696
Back to top

Keywords

About this book

This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

Editors and Affiliations

  • Institute for Molecular Vaccines, Heidelberg, Germany

    Matthias Giese

About the editor

Dr. Matthias Giese, Heidelberg, Germany

Bibliographic Information

  • Book Title: Molecular Vaccines

  • Book Subtitle: From Prophylaxis to Therapy - Volume 2

  • Editors: Matthias Giese

  • DOI: https://doi.org/10.1007/978-3-319-00978-0

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer International Publishing Switzerland 2014

  • Hardcover ISBN: 978-3-319-00977-3Published: 20 November 2013

  • Softcover ISBN: 978-3-319-37675-2Published: 23 August 2016

  • eBook ISBN: 978-3-319-00978-0Published: 08 November 2013

  • Edition Number: 1

  • Number of Pages: XXVIII, 423

  • Number of Illustrations: 24 b/w illustrations, 74 illustrations in colour

  • Topics: Vaccine, Immunology, Molecular Medicine

Publish with us

Policies and ethics

Back to top

Search

Navigation